Occult lymph node metastasis is not a favorable factor for resected NSCLC patients

被引:3
作者
Cai, Jing-Sheng [1 ,2 ]
Yang, Fan [1 ,2 ]
Wang, Xun [1 ,2 ]
机构
[1] Peking Univ, Peoples Hosp, Dept Thorac Surg, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Peking Univ, Peoples Hosp, Thorac Oncol Inst, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
Non-small cell lung cancer; Occult lymph node metastasis; Survivals; Predictive factors; CELL LUNG-CANCER; SURVIVAL; NUMBER; CLASSIFICATION;
D O I
10.1186/s12885-023-11189-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThis study was to compare the clinical presentations and survivals between the non-small cell lung cancer (NSCLC) patients with occult lymph node metastasis (OLNM) and those with evident lymph node metastasis (ELNM). We also intended to analyze the predictive factors for OLNM.MethodsKaplan-Meier method with log-rank test was used to compare survivals between groups. Propensity score matching (PSM) was used to reduce bias. The least absolute shrinkage and selection operator (LASSO)-penalized Cox multivariable analysis was used to identify the prognostic factors. Random forest was used to determine the predictive factors for OLNM.ResultsA total of 2,067 eligible cases (N0: 1,497 cases; occult N1: 165 cases; evident N1: 54 cases; occult N2: 243 cases; evident N2: 108 cases) were included. The rate of OLNM was 21.4%. Patients with OLNM were tend to be female, non-smoker, adenocarcinoma and had smaller-sized tumors when compared with the patients with ELNM. Survival curves showed that the survivals of the patients with OLNM were similar to those of the patients with ELNM both before and after PSM. Multivariable Cox analysis suggested that positive lymph nodes (PLN) was the only prognostic factor for the patients with OLNM. Random forest showed that clinical tumor size was an important predictive factor for OLNM.ConclusionsOLNM was not rare. OLNM was not a favorable sign for resected NSCLC patients with lymph node metastasis. PLN determined the survivals of the patients with OLNM. Clinical tumor size was a strong predictive factor for OLNM.
引用
收藏
页数:11
相关论文
共 32 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications
    Andre, F
    Grunenwald, D
    Pignon, JP
    Dujon, A
    Pujol, JL
    Brichon, PY
    Brouchet, L
    Quoix, E
    Westeel, V
    Le Chevalier, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2981 - 2989
  • [3] An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
    Austin, Peter C.
    [J]. MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (03) : 399 - 424
  • [4] Occult lymph node metastases in clinical N0/N1 NSCLC; A single center in-depth analysis
    Beyaz, Ferhat
    Verhoeven, Roel L. J.
    Schuurbiers, Olga C. J.
    Verhagen, Ad F. T. M.
    van der Heijden, Erik H. F. M.
    [J]. LUNG CANCER, 2020, 150 : 186 - 194
  • [5] Lymphovascular invasion: A non-sized T descriptor for stage IA non-small cell lung cancer
    Cai, Jing-Sheng
    Wang, Xun
    Yang, Fei
    Li, Yun
    Qiu, Man-Tang
    [J]. THORACIC CANCER, 2022, 13 (17) : 2413 - 2420
  • [6] DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model
    Chen, Zisheng
    Xiong, Shan
    Li, Jianfu
    Ou, Limin
    Li, Caichen
    Tao, Jinsheng
    Jiang, Zeyu
    Fan, Jianbing
    He, Jianxing
    Liang, Wenhua
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 280 - +
  • [7] Lung cancer with PET/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: a multicentre study
    Deng, Jiajun
    Zhong, Yifan
    Wang, Tingting
    Yang, Minglei
    Ma, Minjie
    Song, Yongxiang
    She, Yunlang
    Chen, Chang
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (07) : 2414 - 2424
  • [8] Mandatory Nodal Evaluation During Resection of Clinical T1a Non-Small Cell Lung Cancers
    Dezube, Aaron R.
    Mazzola, Emanuele
    Deeb, Ashley
    Wiener, Daniel C.
    Marshall, M. Blair
    Rochefort, Mathew W.
    Jaklitsch, Michael T.
    [J]. ANNALS OF THORACIC SURGERY, 2022, 113 (05) : 1583 - 1590
  • [9] Should we operate on microscopic N2 non-small cell lung cancer?
    Fontaine, Eustace
    McShane, James
    Carr, Martyn
    Shackcloth, Michael
    Mediratta, Neeraj
    Page, Richard
    Poullis, Michael
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (06) : 956 - 961
  • [10] Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US
    Ganti, Apar Kishor
    Klein, Alyssa B.
    Cotarla, Ion
    Seal, Brian
    Chou, Engels
    [J]. JAMA ONCOLOGY, 2021, 7 (12) : 1824 - 1832